Gilead Sciences, Inc. (GILD)
136.30
+2.82
(+2.11%)
USD |
NASDAQ |
May 06, 16:00
136.33
+0.03
(+0.02%)
After-Hours: 20:00
Gilead Sciences Market Cap : 169.21B for May 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 178.80B |
| Biogen, Inc. | 28.15B |
| Johnson & Johnson | 540.71B |
| Arcellx, Inc. | 6.729B |
| Moderna, Inc. | 19.36B |
Market Cap Related Metrics
| PE Ratio | 20.10 |
| PS Ratio | 5.810 |
| PEG Ratio | 0.0115 |
| Price to Book Value | 7.453 |
| Price to Free Cash Flow | 18.09 |
| Price | 136.30 |
| Earnings Yield | 4.98% |
| PEGY Ratio | 0.0115 |
| Operating PE Ratio | 14.47 |
| Normalized PE Ratio | 18.01 |